Bryan Goldman
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 1
-
- Heart Rate Variability and Autonomic Control 1
- Cardiovascular Function and Risk Factors 1
- Co-authors
- Thomas A. Wadden (3 shared papers)Ildiko Lingvay (2 shared papers)Domenica Rubino (2 shared papers)Sean Wharton (2 shared papers)Dror Dicker (2 shared papers)Mette Skovhus Thomsen (2 shared papers)Melanie J. Davies (2 shared papers)Salvatore Calanna (2 shared papers)
- Journals
- Journal of the American College of Cardiology (2 papers)Circulation (2 papers)Obesity (2 papers)Diabetes Obesity and Metabolism (2 papers)Haemophilia (1 paper)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Bryan Goldman
14 papers receiving 649 citations
Bryan Goldman's Hit Papers
Peers
Comparison fields: 5 of 57
- Endocrinology, Diabetes and Metabolism 446
- Pharmacology 168
- Physiology 69
- Nephrology 16
- Molecular Biology 150
Countries citing papers authored by Bryan Goldman
This map shows the geographic impact of Bryan Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Goldman more than expected).
Fields of papers citing papers by Bryan Goldman
This network shows the impact of papers produced by Bryan Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Goldman. The network helps show where Bryan Goldman may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 Hit paper breakdown → | 2020 | 229 |
| 2 | 2021 | 119 | |
| 3 | 2018 | 108 | |
| 4 | 2020 | 82 | |
| 5 | 2024 | 59 | |
| 6 | 2016 | 21 | |
| 7 | 2023 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2018 | 7 | |
| 10 | 2021 | 5 | |
| 11 | 2018 | 4 | |
| 12 | 2019 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2025 | 1 |
About Bryan Goldman
Bryan Goldman is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Statistics and Probability and Hematology, having authored 14 papers that have together received 662 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (3 papers), Statistical Methods in Clinical Trials (1 paper), Diabetes Management and Research (1 paper), Heart Rate Variability and Autonomic Control (1 paper), Cardiovascular Function and Risk Factors (1 paper), Pancreatic function and diabetes (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (446 citations), Pharmacology (168 citations), Physiology (69 citations), Nephrology (16 citations) and Molecular Biology (150 citations). Bryan Goldman has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Thomas A. Wadden, Ildiko Lingvay, Domenica Rubino, Sean Wharton, Dror Dicker, Mette Skovhus Thomsen, Melanie J. Davies, Salvatore Calanna, Ofri Mosenzon and Neil R Poulter. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, Obesity, Diabetes Obesity and Metabolism and Haemophilia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.